ACC 2014 Report: Benefits of treating heart attack patients with a cheap drug
The 6-month follow-up data from the METOCARD-CNIC trial are published in the Journal of the American College of Cardiology.
The 6-month follow-up data from the METOCARD-CNIC trial are published in the Journal of the American College of Cardiology.
Maria Dalby reporting on the Oral Presentation by Lluís Guirado, Fundació Puigvert, Barcelona, Spain. Renal function is a strong predictor of patient and graft survival after renal transplantation,… read more.
Maria Dalby reporting from the annual British Transplantation Society meeting in Glasgow by Anthony Dorling, King’s College London – Chronic rejection is a major cause of graft failure… read more.
A novel antiviral drug may protect people infected with the measles from getting sick and prevent them from spreading the virus to others, an international team of researchers… read more.
by Bruce Sylvester – Following a first ischemic stroke, patients who keep their blood pressure well controlled appear to halve their risk of a second stroke, researchers reported… read more.
by Bruce Sylvester – Pregnant women who take non-steroidal anti-inflammatory drugs do not increase their risk of miscarriages, researchers report in a study published on Feb. 3, 2014… read more.
Little evidence other complementary or alternative therapies work. A new guideline from the American Academy of Neurology suggests that there is little evidence that most complementary or alternative… read more.
by Gary Finnegan: ‘Don’t make me angry. You wouldn’t like me when I’m angry.’ That famous line from the Incredible Hulk was a warning to anyone in danger… read more.
by Gary Finnegan: The European Medicines Agency (EMA) has recommended approval of several new medicines.
by Gary Finnegan – The European drug regulator has given a paediatric-use marketing authorisation (PUMA) for Hemangiol to treat proliferation of infantile haemangioma.
by Bruce Sylvester: The antidepressant citalopram (Celexa/Cipramil, and generic) significantly reduces agitation among patients with Alzheimer’s disease, researchers reported in the Feb. 19, 2014 issue of JAMA/Journal of… read more.
by Bruce Sylvester: The antidepressant citalopram (Celexa/Cipramil, and generic) significantly reduces agitation among patients with Alzheimer’s disease, researchers reported in the Feb. 19, 2014 issue of JAMA/Journal of… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.